Evidence map›Paper›PMID 32153719›Full record

ArticleThe Pan African medical journal2019

Community stakeholder engagement during a vaccine demonstration project in Nigeria: lessons on implementation of the good participatory practice guidelines.

Morenike Oluwatoyin Folayan, Florita Durueke, Wika Gofwen, Godwin Godo-Odemijie, Chuks Okonkwo, Bali Nanmak, Sophia Osawe, Evaezi Okporoko, Alash'le Abimiku

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Morenike Oluwatoyin FolayanNew HIV Vaccine and Microbicide Advocacy Society, Abuja, Nigeria.
Florita DuruekeNew HIV Vaccine and Microbicide Advocacy Society, Abuja, Nigeria.
Wika GofwenNew HIV Vaccine and Microbicide Advocacy Society, Abuja, Nigeria.
Godwin Godo-OdemijieNew HIV Vaccine and Microbicide Advocacy Society, Abuja, Nigeria.
Chuks OkonkwoNew HIV Vaccine and Microbicide Advocacy Society, Abuja, Nigeria.
Bali NanmakNew HIV Vaccine and Microbicide Advocacy Society, Abuja, Nigeria.
Sophia OsawePlateau State Human Virology Research Center, Jos Institute of Human Virology, Abuja, Nigeria.
Evaezi OkporokoPlateau State Human Virology Research Center, Jos Institute of Human Virology, Abuja, Nigeria.
Alash'le AbimikuPlateau State Human Virology Research Center, Jos Institute of Human Virology, Abuja, Nigeria.
Institute of Human Virology · NGObafemi Awolowo University · NGUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo report on the successes and challenges with implementing the good participatory practice guidelines for the Nigerian Canadian Collaboration on AIDS Vaccine (NICCAV) project.

methodsAn open and close ended questionnaire was administered to 25 randomly selected community stakeholders on the project. The questions sought information on perception about the community entry, constitution and function of the community advisory board (CAB) and community based organization (CBO), media engagement process, and research literacy programmes. The quantitative and qualitative data were analysed and findings triangulated.

resultsThe project exceeded its targets on CBO engagement and community members reached. Stakeholders had significant improvement in knowledge about HIV vaccine research design and implementation (p=0.004). All respondents felt satisfied with the community entry, CAB constitution process, function and level of media engagement; 40% were satisfied with the financial support provided; 70% felt the community awareness and education coverage was satisfactory; and 40% raised concerns about the study site selection with implications for study participants' recruitment.

conclusionThe NICCAV community stakeholder engagement model produced satisfactory outcomes for both researchers and community stakeholders. The inclusion of an advocacy and monitoring plan enabled it to identify important challenges that were of ethical concerns for the study.

Indexed as

Practice Guidelines as TopicStakeholder ParticipationAIDS VaccinesCommunity-Based Participatory ResearchHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansNigeriaSurveys and QuestionnairesAIDS VaccinesCommunity stakeholder engagementHIV vaccineNigeria

Identifiers

PMID32153719
PMCPMC7046105
OpenAlexW3007162825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.